多区域亚临床动脉粥样硬化的短期进展
研究纳入3514名PESA研究参与者(45.7±4.2岁,63%男性),在基线和2.8年后进行二维血管超声、三维血管超声和冠状动脉钙化评分。结果显示41.5%的参与者出现短期(3年)动脉粥样硬化进展,外周血管超声检出率高于CACS,且36.5%的低危人群也出现进展。
要点
- 多模态影像可在短期内检出约四成健康中年人的亚临床动脉粥样硬化进展。
- 外周血管二维/三维超声对进展的检出率高于冠状动脉钙化评分。
- 血脂异常是进展最强的可干预危险因素,低危人群也可发生进展。
核心结论
- 在 apparent healthy 中年人群中,41.5%在短期(3年)内出现亚临床动脉粥样硬化进展,外周超声检出率高于CACS。
- 疾病进展与几乎所有心血管危险因素及估计风险相关,但36.5%的低危参与者仍出现进展。
研究设计与样本
- PESA(Progression of Early Subclinical Atherosclerosis)研究,纳入3514名参与者(45.7±4.2岁,63%男性)。
- 基线和2.8年后进行二维血管超声(腹主动脉、颈动脉、髂动脉、股动脉)、三维血管超声(颈动脉和股动脉斑块体积)和冠状动脉钙化评分。
主要发现
- 短期(3年)动脉粥样硬化进展检出率为41.5%(二维超声26.4%,三维超声21.3%,CACS 11.5%)。
- 新发动脉粥样硬化占总进展约三分之一,二维超声和三维超声分别为29.1%和16.6%,CACS为2.9%。
- 基线三种模态均检出疾病的参与者(n=432)也显示显著进展:二维超声斑块数中位数1(IQR -1至3),三维超声体积7.6 mm3(IQR -32.2至57.6 mm3),CACS 21.6 Agatston单位(IQR 4.8至62.6)。
- 年龄、性别、血脂异常、高血压、吸烟和早发心血管病家族史均促进进展,血脂异常是最强的可干预危险因素。
- 36.5%的低危参与者检出进展。
临床怎么用
- 对于中年健康人群,可考虑使用外周血管超声(二维/三维)评估亚临床动脉粥样硬化进展,其检出率高于CACS。
- 即使估计10年风险为低危,也应关注亚临床动脉粥样硬化进展,尤其是合并血脂异常等危险因素者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atherosclerosis progression predicts cardiovascular events; however, progression of multiterritorial subclinical atherosclerosis is incompletely understood. OBJECTIVES: This study sought to study short-term progression of atherosclerosis using different noninvasive imaging techniques and their relationship with cardiovascular risk. METHODS: The study included 3,514 PESA (Progression of Early Subclinical Atherosclerosis) study participants (45.7 ± 4.2 years of age; 63% men). Participants underwent 2-dimensional vascular ultrasound (2DVUS) of abdominal aorta, carotid, iliac, and femoral territories to determine a plaque number score; 3DVUS to quantify carotid and femoral plaque volume; and coronary artery calcium score (CACS) at baseline and 2.8 years later. The authors calculated the rate of new disease incidence and changes in disease extent. Logistic regression models were used to evaluate associations of progression rates with baseline cardiovascular risk factors and estimated 10-year risk. RESULTS: Imaging detected short-term (3-year) atherosclerosis progression in 41.5% of participants (26.4% by 2DVUS, 21.3% by 3DVUS, and 11.5% by CACS), particularly in peripheral territories examined by vascular ultrasound. New atherosclerosis onset accounted for approximately one-third of total progression, also more frequently by 2DVUS and 3DVUS (29.1% and 16.6%, respectively), than by CACS (2.9%). Participants with baseline disease by all 3 modalities (n = 432) also showed significant atherosclerosis progression (median: 1 plaque [interquartile range (IQR): -1 to 3 plaques] by 2DVUS; 7.6 mm3 [IQR: -32.2 to 57.6 mm3] by 3DVUS; and 21.6 Agatston units [IQR: 4.8 to 62.6 Agatston units] by CACS). Age, sex, dyslipidemia, hypertension, smoking, and family history of premature cardiovascular disease contributed to progression, with dyslipidemia the strongest modifiable risk factor. Although disease progression correlated with cardiovascular risk, progression was detected in 36.5% of participants categorized as low risk. CONCLUSIONS: With this multimodal and multiterritorial approach, the authors detected short-term progression of early subclinical atherosclerosis in a substantial proportion (41.5%) of apparently healthy middle-aged men and women, more frequently by peripheral 2D/3DVUS than by CACS. Disease progression, as defined in this study, correlated with almost all cardiovascular risk factors and estimated risk. (Progression of Early Subclinical Atherosclerosis [PESA]; NCT01410318).
引用
- López-Melgar B, Fernández-Friera L, Oliva B, et al. Short-Term Progression of Multiterritorial Subclinical Atherosclerosis. J Am Coll Cardiol. 2020. PMID: 32273027. doi:10.1016/j.jacc.2020.02.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。